enGene Therapeutics (ENGN) Stock Price & Financial Analysis
enGene Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About enGene Therapeutics
What is the current stock price for ENGN?
As of the latest trading session, ENGN stock trades at $1.75. The 52-week range is $1.40–$12.25, with a day range of $1.70–$1.76.
What is the P/E ratio for ENGN?
The P/E ratio (Price-to-Earnings) for ENGN is shown in the Key Statistics section. This valuation metric helps compare enGene Therapeutics Inc. to industry peers.
Does ENGN pay dividends?
enGene Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for ENGN?
Based on 1 analyst, the consensus for ENGN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of ENGN?
enGene Therapeutics's market capitalization is $117.7M, classifying it as a micro-cap company. enGene Therapeutics operates in the Healthcare sector within the Biotechnology industry.